Epirubicin plus cyclophosphamide vs. weekly paclitaxel as...

Epirubicin plus cyclophosphamide vs. weekly paclitaxel as primary systemic therapy in patients with stage II and III breast cancer: randomized phase II study

M. Miyashita, Kohno, S. Takao, K. Wakita, M. Konishi, H. Yoshimura, M. Kubota, Y. Kasahara, Y. Sumi, I. Kokufu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Year:
2006
Language:
english
DOI:
10.1016/s1359-6349(06)80389-7
File:
PDF, 136 KB
english, 2006
Conversion to is in progress
Conversion to is failed